Entry - #300354 - INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC - OMIM
# 300354

INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC


Alternative titles; symbols

MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE
CABEZAS SYNDROME
MENTAL RETARDATION, X-LINKED, SYNDROMIC 15; MRXS15
MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT
MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE; MRSS


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
Xq24 Intellectual developmental disorder, X-linked syndromic, Cabezas type 300354 XLR 3 CUL4B 300304
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- X-linked recessive
GROWTH
Height
- Short stature (5th percentile)
Weight
- Central obesity
- Low birthweight (<10th percentile)
HEAD & NECK
Head
- Macrocephaly, relative
Face
- High forehead
- Coarse face
- Prognathia
Ears
- Malformed ears
- Abnormally positioned ears
- Hypoplastic ear lobes
Eyes
- Small, downslanting palpebral fissures
Nose
- Depressed nasal bridge
- Large bulbous nose
Mouth
- Macrostomia
- Prominent lower lip
- Macroglossia
CHEST
Breasts
- Gynecomastia
GENITOURINARY
External Genitalia (Male)
- Hypospadias
- Small penis
Internal Genitalia (Male)
- Cryptorchidism
- Small testes
SKELETAL
- Joint laxity
Spine
- Kyphosis
Hands
- Small hands
- Brachydactyly
Feet
- Brachydactyly
- Small feet
- Pes cavus
- Pes planus
- Wide sandal gap
SKIN, NAILS, & HAIR
Skin
- Striae
MUSCLE, SOFT TISSUES
- Hypotonia
- Atrophy of the lower leg muscles
NEUROLOGIC
Central Nervous System
- Mental retardation
- Speech delay, severe
- Lack of speech development
- Tremor
- Decreased fine motor coordination
- Seizures (onset <2 years)
- Abnormal gait
- Ataxic gait
- Ventriculomegaly
- Cortical malformations (in some patients)
- Polymicrogyria (in some patients)
- Simplified gyral pattern (in some patients)
- Cortical dysplasia (in some patients)
- White matter abnormalities (in some patients)
- Thin corpus callosum (in some patients)
- Cerebellar vermis atrophy (in some patients)
Behavioral Psychiatric Manifestations
- Aggressive outbursts
- Hyperactivity
- Mood swings
- Decreased attention span
VOICE
- Impaired/absent speech
ENDOCRINE FEATURES
- Delayed puberty (in some patients)
- Hypogonadism (in some patients)
MISCELLANEOUS
- Dysmorphic facial features are variable
MOLECULAR BASIS
- Caused by mutation in the cullin 4B gene (CUL4B, 300304.0001)
Intellectual developmental disorder, X-linked syndromic - PS309510 - 56 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
Xp22.2 Raynaud-Claes syndrome XLD 3 300114 CLCN4 302910
Xp22.2 Basilicata-Akhtar syndrome XLD 3 301032 MSL3 300609
Xp22.2 Intellectual developmental disorder, X-linked syndromic, Pilorge type XL 3 301076 GLRA2 305990
Xp22.2 Pettigrew syndrome XLR 3 304340 AP1S2 300629
Xp22.12 Intellectual developmental disorder, X-linked syndromic, Houge type XL 3 301008 CNKSR2 300724
Xp22.11 Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type XLR 3 309583 SMS 300105
Xp22.11 MEHMO syndrome XLR 3 300148 EIF2S3 300161
Xp22.11 Intellectual developmental disorder, X-linked syndromic 37 XL 3 301118 ZFX 314980
Xp22.11-p21.3 Van Esch-O'Driscoll syndrome XLR 3 301030 POLA1 312040
Xp21.3 Partington syndrome XLR 3 309510 ARX 300382
Xp21.1-p11.23 Intellectual developmental disorder, X-linked syndromic 17 XLR 2 300858 MRXS17 300858
Xp11 ?Intellectual developmental disorder, X-linked syndromic 12 XL 2 309545 MRXS12 309545
Xp11.4 Intellectual developmental disorder, X-linked syndromic, Hedera type XLR 3 300423 ATP6AP2 300556
Xp11.4 Intellectual developmental disorder, X-linked syndromic, Snijders Blok type XLD, XLR 3 300958 DDX3X 300160
Xp11.4 Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia XL 3 300749 CASK 300172
Xp11.3-q22 Intellectual developmental disorder, X-linked syndromic 7 XL 2 300218 MRXS7 300218
Xp11.2 Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type XL 2 300434 SDSX 300434
Xp11.23 Renpenning syndrome XLR 3 309500 PQBP1 300463
Xp11.22 Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type XLR 3 300534 KDM5C 314690
Xp11.22 Intellectual developmental disorder, X-linked syndromic, Turner type XL 3 309590 HUWE1 300697
Xp11.22 Intellectual developmental disorder, X-linked syndromic, Siderius type XLR 3 300263 PHF8 300560
Xp11.22 Prieto syndrome XLR 3 309610 WNK3 300358
Xp11.22 Intellectual developmental disorder, X-linked syndromic 16 XLR 3 305400 FGD1 300546
Xp11.22 Aarskog-Scott syndrome XLR 3 305400 FGD1 300546
Xq11.2 Wieacker-Wolff syndrome XLR 3 314580 ZC4H2 300897
Xq12-q21.31 Intellectual developmental disorder, X-linked syndromic 9 2 300709 MRXS9 300709
Xq12 Wilson-Turner syndrome XLR 3 309585 LAS1L 300964
Xq12 Intellectual developmental disorder, X-linked syndromic, Billuart type XLR 3 300486 OPHN1 300127
Xq13-q21 Martin-Probst syndrome XLR 2 300519 MRXSMP 300519
Xq13.1 ?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia XLR 3 300472 IGBP1 300139
Xq13.1 Lujan-Fryns syndrome XLR 3 309520 MED12 300188
Xq13.1 Intellectual developmental disorder, X-linked syndromic 34 XL 3 300967 NONO 300084
Xq13.1 Intellectual developmental disorder, X-linked syndromic 33 XLR 3 300966 TAF1 313650
Xq13.2 Intellectual developmental disorder, X-linked syndromic, Abidi type XL 2 300262 MRXSAB 300262
Xq13.2 Tonne-Kalscheuer syndrome XL 3 300978 RLIM 300379
Xq21.33-q23 Intellectual developmental disorder, X-linked syndromic, Chudley-Schwartz type XLR 2 300861 MRXSCS 300861
Xq22.1 Intellectual developmental disorder, X-linked syndromic, Bain type XLD 3 300986 HNRNPH2 300610
Xq22.3 Arts syndrome XLR 3 301835 PRPS1 311850
Xq24 Intellectual developmental disorder, X-linked syndromic, Nascimento type XLR 3 300860 UBE2A 312180
Xq24 Intellectual developmental disorder, X-linked syndromic 14 XLR 3 300676 UPF3B 300298
Xq24 Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type XLR 3 301039 NKAP 300766
Xq24 Intellectual developmental disorder, X-linked syndromic, Cabezas type XLR 3 300354 CUL4B 300304
Xq25 Intellectual developmental disorder, X-linked syndromic, Wu type XLR 3 300699 GRIA3 305915
Xq26.1 Intellectual developmental disorder, X-linked syndromic, Raymond type XL 3 300799 ZDHHC9 300646
Xq26.2 ?Paganini-Miozzo syndrome XLR 3 301025 HS6ST2 300545
Xq26.2 Borjeson-Forssman-Lehmann syndrome XLR 3 301900 PHF6 300414
Xq26.3 Intellectual developmental disorder, X-linked syndromic, Christianson type XL 3 300243 SLC9A6 300231
Xq26.3 ?Intellectual developmental disorder, X-linked syndromic, Shashi type XLR 3 300238 RBMX 300199
Xq26.3 ?Intellectual developmental disorder, X-linked syndromic, Gustavson type XLR 3 309555 RBMX 300199
Xq27.3 Fragile X syndrome XLD 3 300624 FMR1 309550
Xq28 Intellectual developmental disorder, X-linked 109 XLR 3 309548 AFF2 300806
Xq28 Intellectual developmental disorder, X-linked syndromic 13 XLR 3 300055 MECP2 300005
Xq28 Intellectual developmental disorder, X-linked syndromic, Lubs type XLR 3 300260 MECP2 300005
Xq28 Intellectual developmental disorder, X-linked syndromic 35 XLR 3 300998 RPL10 312173
Xq28 Intellectual developmental disorder, X-linked syndromic, Armfield type XLR 3 300261 FAM50A 300453
Xq28 ?Intellectual developmental disorder, X-linked syndromic 32 XLR 3 300886 CLIC2 300138

TEXT

A number sign (#) is used with this entry because of evidence that the Cabezas type of X-linked syndromic intellectual developmental disorder (MRXSC) is caused by mutation in the CUL4B gene (300304) on chromosome Xq23.


Description

The Cabezas type of X-linked syndromic intellectual developmental disorder is characterized primarily by short stature, hypogonadism, and abnormal gait, with other more variable features such as speech delay, prominent lower lip, and tremor (Cabezas et al., 2000).


Clinical Features

In a population survey for common hereditary diseases conducted in China in 1990, Wei et al. (1993) identified a family with X-linked mental retardation in 5 affected males in 4 sibships. The distinguishing manifestations were short stature, patulous lips, difficulty in speech, short thumbs and little fingers with adduction, hypotonia at age less than 10 years, and later hypertonia, restlessness, and seizures. Other features included pes planus, and 2 had small testes, with delayed sex development in 1. IQ ranged from 40 through 57. Obligate carrier females were clinically normal except for rather large hands with deep palmar and finger creases with rhagades. The disorder was initially classified as Smith-Fineman-Myers syndrome (SFMS; 309580), based on mild facial dysmorphisms, such as microcephaly, hypertelorism, micrognathia, and macrostomia. However, on reexamination of this family, Zou et al. (2007) noted that no remarkable facial features were present; in particular, the small palpebral fissures, flat nasal bridge, micrognathia, and hypertelorism characteristic of SFMS were not obvious. However, several other physical features were distinct, including short stature, brachydactyly, macroglossia, and a unique gait, with toes pointing inwards.

Cabezas et al. (2000) reported a large family in which 7 males with mental retardation were identified, with transmission from 5 normal or minimally affected female carriers and an absence of male-to-male transmission. Characteristic clinical features included short stature, prominent lower lip, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, abnormal gait, tremor, and decreased fine motor coordination. Affected subjects had impaired speech and decreased attention span. For the 3 individuals for whom IQ data were available, scores ranged from 29 to 54; affected males were described as being retarded by clinical examination and history. One female carrier was examined and had normal growth and development but had been evaluated for Tourette syndrome (137580) and had several tics, memory problems, and learning difficulties. On examination at age 12 years, she had a thin habitus and a mild tremor in the upper extremities.

Vitale et al. (2001) described a large family in Sardinia, Italy, with X-linked mental retardation. The phenotype observed in the 8 affected males included severe mental retardation, lack of speech, coarse face, distinctive skeletal features with short stature, brachydactyly, small downslanting palpebral fissures, large bulbous nose, hypoplastic earlobes, and macrostomia. Carrier females were not mentally retarded, although some of them had mild dysmorphic features such as minor earlobe abnormalities, as well as language and learning problems. Levels of growth hormone were normal. Vitale et al. (2001) distinguished the disorder in this family from that reported by Hamel et al. (1996), in which affected males had panhypopituitarism and mental retardation (300123).

Tarpey et al. (2007) discussed the clinical features of the family described by Cabezas et al. (2000) and 7 additional families. During the adolescence of affected subjects, a syndrome emerged with delayed puberty, hypogonadism, relative macrocephaly, moderate short stature, central obesity, unprovoked aggressive outbursts, fine intention tremor, pes cavus, and abnormalities of the toes. Seven families were white, and 1 was of Asian descent.

Ravn et al. (2012) described a Danish monozygotic twin pair concordant for X-linked mental retardation resulting from a deletion encompassing most of the CUL4B gene. Ravn et al. (2012) found that the twins shared many of the features in patients previously reported with mutation in the CUL4B gene, including moderate mental retardation with pronounced language deficit, short stature, truncal obesity, relative macrocephaly, characteristic facial dysmorphisms, tremor, and seizures. In addition, twin A exhibited intrauterine growth retardation, and twin B had scaphocephaly due to premature fusion of the sagittal suture.

Vulto-van Silfhout et al. (2015) reported 24 patients from 10 families with MRXSC caused by mutation in the CUL4B gene. The phenotype was similar to that reported previously. All patients had intellectual disability with severe speech impairment. Other variable neurologic features included behavioral problems (59%), gait abnormalities (48%), tremor (45%), and seizures (32%). Additional prominent features included hypogonadism (85%), short stature (77%), small hands (74%), kyphosis (35%), gynecomastia (33%), and macrocephaly (32%). Dysmorphic facial features included high forehead (76%), prominent lower lip (78%), and malformed and/or abnormally positioned ears (89%) The facial phenotype changed with age: younger patients tended to have a depressed nasal bridge with a bulbous tip (55%), while older patients had more coarse facial features with hyperplastic supraorbital ridges (77%) and prognathia (68%). Variable neuroimaging abnormalities were noted in 10 of 12 patients who underwent imaging studies. The most severe changes included severe ventriculomegaly with bilateral persylvian polymicrogyria or a simplified gyral pattern, and a cortical dysplasia. More subtle changes observed in some patients included mildly diminished white matter volume, white matter hyperintensities, thin corpus callosum, and cerebellar vermis atrophy.


Mapping

Cabezas et al. (2000) performed linkage analysis on their family with syndromic X-linked mental retardation and achieved a maximum lod score of 2.80 at marker DXS1212 and 2.76 at DXS425, within a region defined by markers DXS424 and DXS1047 (Xq24-q25).

Using linkage analysis, Gong et al. (1999) mapped the phenotype in the family reported by Wei et al. (1993) to a 20-Mb interval between DXS8064 and DXS8050 on chromosome Xq25. Liu et al. (2002) excluded linkage of the ATRX gene (300032) at Xq13 to the disorder in this family, confirming locus heterogeneity for the disorder. Liu et al. (2004) narrowed the candidate interval to a 10.18-Mb region between XSTR3 and XSTR4.

By linkage analysis in a large Italian family segregating a syndromic form of mental retardation, Vitale et al. (2001) obtained a maximum lod score of 3.61 with marker DXS1001 on Xq24. Recombination observed with flanking markers identified a region of 16 cM for further study.


Pathogenesis

Kerzendorfer et al. (2010) showed that cells from patients with mental retardation, macrocephaly, tremor, peripheral neuropathy, and CUL4B mutations exhibited sensitivity to camptothecin (CPT), impaired CPT-induced topoisomerase I (TOP1; 126420) degradation and ubiquitination, suggesting that TOP1 may be a novel CUL4-dependent substrate. These cells exhibited increased levels of CPT-induced DNA breaks, as well as overexpression of the known CUL4-dependent substrates CDT1 (605525) and p21 (CDKN1A; 116899).


Molecular Genetics

By a systematic mutational screen of the X chromosome in 250 families with multiple members with X-linked mental retardation, Tarpey et al. (2007) found 8 families who carried mutations in the CUL4B gene (see, e.g., 300304.0001-300304.0003) on Xq24. One of these was the family reported by Cabezas et al. (2000). CUL4B is a ubiquitin E3 ligase subunit implicated in the regulation of several biologic processes, and CUL4B was the first identified XLMR gene that encodes an E3 ubiquitin ligase. The relatively high frequency of CUL4B mutations in this series (8/250) indicated that it is one of the most commonly mutated genes underlying XLMR and suggested that its introduction into clinical diagnostics should be a high priority.

In the family reported by Wei et al. (1993), Zou et al. (2007) detected a nonsense mutation in the CUL4B gene (R388X; 300304.0002) that rendered the peptide completely devoid of the C-terminal domain. Mutant mRNA underwent nonsense-mediated decay (NMD). In peripheral leukocytes of obligate carriers a strong selection against cells expressing the mutant allele resulted in an extremely skewed X chromosome inactivation pattern. These findings pointed to the functional significance of CUL4B in cognition and in other aspects of human development.

Tarpey et al. (2009) sequenced the coding exons of the X chromosome in 208 families with X-linked mental retardation. They identified 5 nonrecurrent mutations in the CUL4B gene that segregated completely with mental retardation in the families and were not identified in unaffected family members. In addition to mental retardation, affected family members had relative macrocephaly, hypogonadism, central obesity, and tremor.

In affected members of the family with X-linked mental retardation and short stature originally reported by Vitale et al. (2001), Londin et al. (2014) identified a hemizygous splice site mutation in the CUL4B gene (300304.0004). The mutation, which was found by exome sequencing of the X chromosome, was predicted to result in either aberrant or no splicing of intron 7, but functional studies or studies of patient cells were not performed. Exome sequencing also identified a T-to-G transversion in the 3-prime UTR of the KAISO gene (ZBTB33; 300329) that segregated with the phenotype, but functional studies did not show a significant effect on gene expression. Londin et al. (2014) concluded that the phenotype resulted primarily from the CUL4B mutation, but noted that the KAISO variant may be a contributing factor.

By massive parallel sequencing of 407 families with X-linked mental retardation, Vulto-van Silfhout et al. (2015) identified CUL4B mutations in affected members of 8 families (2.0%). Subsequent screening of 29 patients with malformations of cortical development identified CUL4B mutations in 3 patients from 2 families. Ten different mutations were identified in the 10 families, including 5 truncating mutations, 2 splice site variants, an in-frame deletion, an in-frame duplication, and a missense variant (see, e.g., 300304.0005 and 300304.0006). Some of the patients were found to have variable malformations of cerebral development, suggesting that CUL4B has a role in this process.


Cytogenetics

In a patient with X-linked mental retardation with relative macrocephaly, short stature, lack of speech development, hypogonadism, and abnormal gait, Isidor et al. (2010) identified a 60-kb de novo deletion at chromosome Xq24 that encompassed the 3-prime region of the CUL4B gene and the MCTS1 gene (300587). Isidor et al. (2010) concluded that the deletion would result in premature termination and nonsense-mediated mRNA decay of CUL4B.

In a monozygotic twin pair with X-linked mental retardation, Ravn et al. (2012) identified a 28-kb deletion on the X chromosome, which partially encompassed the CUL4B gene and which was inherited from the unaffected mother. Using quantitative PCR, Ravn et al. (2012) mapped the proximal breakpoint within intron 4 of CUL4B and the distal breakpoint 1,000 bp downstream of the 3-prime UTR. X-inactivation studies in the unaffected mother revealed an extremely skewed X-inactivation pattern, consistent with her being an unaffected carrier.


REFERENCES

  1. Cabezas, D. A., Slaugh, R., Abidi, F., Arena, J. F., Stevenson, R. E., Schwartz, C. E., Lubs, H. A. A new X linked mental retardation (XLMR) syndrome with short stature, small testes, muscle wasting, and tremor localises to Xq24-q25. J. Med. Genet. 37: 663-668, 2000. [PubMed: 10978355, related citations] [Full Text]

  2. Gong, Y., Wei, J., Shao, C., Guo, Y., Chen, B., Guo, C., Warman, M. Mapping of the gene responsible for Smith-Fineman-Myers syndrome to Xq25. Chinese J. Med. Genet. 16: 277-280, 1999. Note: Article in Chinese. [PubMed: 10514530, related citations]

  3. Hamel, B. C. J., Smits, A. P. T., Otten, B. J., van den Helm, B., Ropers, H. H., Mariman, E. C. M. Familial X-linked mental retardation and isolated growth hormone deficiency: clinical and molecular findings. Am. J. Med. Genet. 64: 35-41, 1996. [PubMed: 8826446, related citations] [Full Text]

  4. Isidor, B., Pichon, O., Baron, S., David, A., Le Caignec, C. Deletion of the CUL4B gene in a boy with mental retardation, minor facial anomalies, short stature, hypogonadism, and ataxia. Am. J. Med. Genet. 152A: 175-180, 2010. [PubMed: 20014135, related citations] [Full Text]

  5. Kerzendorfer, C., Whibley, A., Carpenter, G., Outwin, E., Chiang, S.-C., Turner, G., Schwartz, C., El-Khamisy, S., Raymond, F. L., O'Driscoll, M. Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks. Hum. Molec. Genet. 19: 1324-1334, 2010. [PubMed: 20064923, images, related citations] [Full Text]

  6. Liu, Q., Gong, Y., Chen, B., Guo, C., Li, J., Guo, Y. [Linkage analysis of X-linked nuclear protein gene in Smith-Fineman-Myers syndrome.] Chinese J. Med. Genet. 19: 22-25, 2002. Note: Article in Chinese. [PubMed: 11836680, related citations]

  7. Liu, Q. J., Gong, Y. Q., Li, J. X., Zhang, X. Y., Gao, G. M., Guo, Y. S. [Fine mapping of Smith-Fineman-Myers syndrome and exclusion of GPC3, GPCR2, MST4 and GLUD2 as candidate genes.] Chinese J. Med. Genet. 21: 198-202, 2004. Note: Article in Chinese. [PubMed: 15192816, related citations]

  8. Londin, E. R., Adijanto, J., Philp, N., Novelli, A., Vitale, E., Perria, C., Serra, G., Alesi, V., Surrey, S., Fortina, P. Donor splice-site mutation in CUL4B is likely cause of X-linked intellectual disability. Am. J. Med. Genet. 164A: 2294-2299, 2014. [PubMed: 24898194, images, related citations] [Full Text]

  9. Ravn, K., Lindquist, S. G., Nielsen, K., Dahm, T. L., Tumer, Z. Deletion of CUL4B leads to concordant phenotype in a monozygotic twin pair. (Letter) Clin. Genet. 82: 292-294, 2012. [PubMed: 22182342, related citations] [Full Text]

  10. Tarpey, P. S., Raymond, F. L., O'Meara, S., Edkins, S., Teague, J., Butler, A., Dicks, E., Stevens, C., Tofts, C., Avis, T., Barthorpe, S., Buck, G. {and 41 others}: Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet. 80: 345-352, 2007. [PubMed: 17236139, images, related citations] [Full Text]

  11. Tarpey, P. S., Smith, R., Pleasance, E., Whibley, A., Edkins, S., Hardy, C., O'Meara, S., Latimer, C., Dicks, E., Menzies, A., Stephens, P., Blow, M., and 67 others. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nature Genet. 41: 535-543, 2009. [PubMed: 19377476, related citations] [Full Text]

  12. Vitale, E., Specchia, C., Devoto, M., Angius, A., Rong, S., Rocchi, M., Schwalb, M., Demelas, L., Paglietti, D., Manca, S., Mastropaolo, C., Serra, G. Novel X-linked mental retardation syndrome with short stature maps to Xq24. Am. J. Med. Genet. 103: 1-8, 2001. [PubMed: 11562927, related citations] [Full Text]

  13. Vulto-van Silfhout, A. T., Nakagawa, T., Bahi-Buisson, N., Haas, S. A., Hu, H., Bienek, M., Vissers, L. E. L. M., Gilissen, C., Tzschach, A., Busche, A., Musebeck, J., Rump, P., Mathijssen, I. B., and 32 others. Variants in CUL4B are associated with cerebral malformations. Hum. Mutat. 36: 106-117, 2015. [PubMed: 25385192, images, related citations] [Full Text]

  14. Wei, J., Chen, B., Jiang, Y., Yang, Y., Guo, Y. Smith-Fineman-Myers syndrome: report on a large family. Am. J. Med. Genet. 47: 307-311, 1993. [PubMed: 8135271, related citations] [Full Text]

  15. Zou, Y., Liu, Q., Chen, B., Zhang, X., Guo, C., Zhou, H., Li, J., Gao, G., Guo, Y., Yan, C., Wei, J., Shao, C., Gong, Y. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet. 80: 561-566, 2007. [PubMed: 17273978, images, related citations] [Full Text]


Cassandra L. Kniffin - updated : 9/3/2015
Cassandra L. Kniffin - updated : 3/23/2015
Jill A. Fahrner - updated : 4/5/2013
George E. Tiller - updated : 11/14/2011
Cassandra L. Kniffin - updated : 1/5/2011
Victor A. McKusick - updated : 1/18/2007
Creation Date:
Michael J. Wright : 8/15/2001
carol : 08/21/2021
alopez : 09/09/2015
ckniffin : 9/3/2015
alopez : 3/25/2015
mcolton : 3/23/2015
ckniffin : 3/23/2015
carol : 9/9/2013
carol : 4/5/2013
carol : 11/17/2011
terry : 11/14/2011
carol : 10/26/2011
wwang : 1/24/2011
ckniffin : 1/5/2011
carol : 11/30/2010
alopez : 10/6/2009
alopez : 1/19/2007
terry : 1/18/2007
ckniffin : 7/20/2005
alopez : 8/15/2001

# 300354

INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC


Alternative titles; symbols

MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE
CABEZAS SYNDROME
MENTAL RETARDATION, X-LINKED, SYNDROMIC 15; MRXS15
MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT
MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE; MRSS


SNOMEDCT: 719811001;   ORPHA: 85293;   DO: 0060822;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
Xq24 Intellectual developmental disorder, X-linked syndromic, Cabezas type 300354 X-linked recessive 3 CUL4B 300304

TEXT

A number sign (#) is used with this entry because of evidence that the Cabezas type of X-linked syndromic intellectual developmental disorder (MRXSC) is caused by mutation in the CUL4B gene (300304) on chromosome Xq23.


Description

The Cabezas type of X-linked syndromic intellectual developmental disorder is characterized primarily by short stature, hypogonadism, and abnormal gait, with other more variable features such as speech delay, prominent lower lip, and tremor (Cabezas et al., 2000).


Clinical Features

In a population survey for common hereditary diseases conducted in China in 1990, Wei et al. (1993) identified a family with X-linked mental retardation in 5 affected males in 4 sibships. The distinguishing manifestations were short stature, patulous lips, difficulty in speech, short thumbs and little fingers with adduction, hypotonia at age less than 10 years, and later hypertonia, restlessness, and seizures. Other features included pes planus, and 2 had small testes, with delayed sex development in 1. IQ ranged from 40 through 57. Obligate carrier females were clinically normal except for rather large hands with deep palmar and finger creases with rhagades. The disorder was initially classified as Smith-Fineman-Myers syndrome (SFMS; 309580), based on mild facial dysmorphisms, such as microcephaly, hypertelorism, micrognathia, and macrostomia. However, on reexamination of this family, Zou et al. (2007) noted that no remarkable facial features were present; in particular, the small palpebral fissures, flat nasal bridge, micrognathia, and hypertelorism characteristic of SFMS were not obvious. However, several other physical features were distinct, including short stature, brachydactyly, macroglossia, and a unique gait, with toes pointing inwards.

Cabezas et al. (2000) reported a large family in which 7 males with mental retardation were identified, with transmission from 5 normal or minimally affected female carriers and an absence of male-to-male transmission. Characteristic clinical features included short stature, prominent lower lip, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, abnormal gait, tremor, and decreased fine motor coordination. Affected subjects had impaired speech and decreased attention span. For the 3 individuals for whom IQ data were available, scores ranged from 29 to 54; affected males were described as being retarded by clinical examination and history. One female carrier was examined and had normal growth and development but had been evaluated for Tourette syndrome (137580) and had several tics, memory problems, and learning difficulties. On examination at age 12 years, she had a thin habitus and a mild tremor in the upper extremities.

Vitale et al. (2001) described a large family in Sardinia, Italy, with X-linked mental retardation. The phenotype observed in the 8 affected males included severe mental retardation, lack of speech, coarse face, distinctive skeletal features with short stature, brachydactyly, small downslanting palpebral fissures, large bulbous nose, hypoplastic earlobes, and macrostomia. Carrier females were not mentally retarded, although some of them had mild dysmorphic features such as minor earlobe abnormalities, as well as language and learning problems. Levels of growth hormone were normal. Vitale et al. (2001) distinguished the disorder in this family from that reported by Hamel et al. (1996), in which affected males had panhypopituitarism and mental retardation (300123).

Tarpey et al. (2007) discussed the clinical features of the family described by Cabezas et al. (2000) and 7 additional families. During the adolescence of affected subjects, a syndrome emerged with delayed puberty, hypogonadism, relative macrocephaly, moderate short stature, central obesity, unprovoked aggressive outbursts, fine intention tremor, pes cavus, and abnormalities of the toes. Seven families were white, and 1 was of Asian descent.

Ravn et al. (2012) described a Danish monozygotic twin pair concordant for X-linked mental retardation resulting from a deletion encompassing most of the CUL4B gene. Ravn et al. (2012) found that the twins shared many of the features in patients previously reported with mutation in the CUL4B gene, including moderate mental retardation with pronounced language deficit, short stature, truncal obesity, relative macrocephaly, characteristic facial dysmorphisms, tremor, and seizures. In addition, twin A exhibited intrauterine growth retardation, and twin B had scaphocephaly due to premature fusion of the sagittal suture.

Vulto-van Silfhout et al. (2015) reported 24 patients from 10 families with MRXSC caused by mutation in the CUL4B gene. The phenotype was similar to that reported previously. All patients had intellectual disability with severe speech impairment. Other variable neurologic features included behavioral problems (59%), gait abnormalities (48%), tremor (45%), and seizures (32%). Additional prominent features included hypogonadism (85%), short stature (77%), small hands (74%), kyphosis (35%), gynecomastia (33%), and macrocephaly (32%). Dysmorphic facial features included high forehead (76%), prominent lower lip (78%), and malformed and/or abnormally positioned ears (89%) The facial phenotype changed with age: younger patients tended to have a depressed nasal bridge with a bulbous tip (55%), while older patients had more coarse facial features with hyperplastic supraorbital ridges (77%) and prognathia (68%). Variable neuroimaging abnormalities were noted in 10 of 12 patients who underwent imaging studies. The most severe changes included severe ventriculomegaly with bilateral persylvian polymicrogyria or a simplified gyral pattern, and a cortical dysplasia. More subtle changes observed in some patients included mildly diminished white matter volume, white matter hyperintensities, thin corpus callosum, and cerebellar vermis atrophy.


Mapping

Cabezas et al. (2000) performed linkage analysis on their family with syndromic X-linked mental retardation and achieved a maximum lod score of 2.80 at marker DXS1212 and 2.76 at DXS425, within a region defined by markers DXS424 and DXS1047 (Xq24-q25).

Using linkage analysis, Gong et al. (1999) mapped the phenotype in the family reported by Wei et al. (1993) to a 20-Mb interval between DXS8064 and DXS8050 on chromosome Xq25. Liu et al. (2002) excluded linkage of the ATRX gene (300032) at Xq13 to the disorder in this family, confirming locus heterogeneity for the disorder. Liu et al. (2004) narrowed the candidate interval to a 10.18-Mb region between XSTR3 and XSTR4.

By linkage analysis in a large Italian family segregating a syndromic form of mental retardation, Vitale et al. (2001) obtained a maximum lod score of 3.61 with marker DXS1001 on Xq24. Recombination observed with flanking markers identified a region of 16 cM for further study.


Pathogenesis

Kerzendorfer et al. (2010) showed that cells from patients with mental retardation, macrocephaly, tremor, peripheral neuropathy, and CUL4B mutations exhibited sensitivity to camptothecin (CPT), impaired CPT-induced topoisomerase I (TOP1; 126420) degradation and ubiquitination, suggesting that TOP1 may be a novel CUL4-dependent substrate. These cells exhibited increased levels of CPT-induced DNA breaks, as well as overexpression of the known CUL4-dependent substrates CDT1 (605525) and p21 (CDKN1A; 116899).


Molecular Genetics

By a systematic mutational screen of the X chromosome in 250 families with multiple members with X-linked mental retardation, Tarpey et al. (2007) found 8 families who carried mutations in the CUL4B gene (see, e.g., 300304.0001-300304.0003) on Xq24. One of these was the family reported by Cabezas et al. (2000). CUL4B is a ubiquitin E3 ligase subunit implicated in the regulation of several biologic processes, and CUL4B was the first identified XLMR gene that encodes an E3 ubiquitin ligase. The relatively high frequency of CUL4B mutations in this series (8/250) indicated that it is one of the most commonly mutated genes underlying XLMR and suggested that its introduction into clinical diagnostics should be a high priority.

In the family reported by Wei et al. (1993), Zou et al. (2007) detected a nonsense mutation in the CUL4B gene (R388X; 300304.0002) that rendered the peptide completely devoid of the C-terminal domain. Mutant mRNA underwent nonsense-mediated decay (NMD). In peripheral leukocytes of obligate carriers a strong selection against cells expressing the mutant allele resulted in an extremely skewed X chromosome inactivation pattern. These findings pointed to the functional significance of CUL4B in cognition and in other aspects of human development.

Tarpey et al. (2009) sequenced the coding exons of the X chromosome in 208 families with X-linked mental retardation. They identified 5 nonrecurrent mutations in the CUL4B gene that segregated completely with mental retardation in the families and were not identified in unaffected family members. In addition to mental retardation, affected family members had relative macrocephaly, hypogonadism, central obesity, and tremor.

In affected members of the family with X-linked mental retardation and short stature originally reported by Vitale et al. (2001), Londin et al. (2014) identified a hemizygous splice site mutation in the CUL4B gene (300304.0004). The mutation, which was found by exome sequencing of the X chromosome, was predicted to result in either aberrant or no splicing of intron 7, but functional studies or studies of patient cells were not performed. Exome sequencing also identified a T-to-G transversion in the 3-prime UTR of the KAISO gene (ZBTB33; 300329) that segregated with the phenotype, but functional studies did not show a significant effect on gene expression. Londin et al. (2014) concluded that the phenotype resulted primarily from the CUL4B mutation, but noted that the KAISO variant may be a contributing factor.

By massive parallel sequencing of 407 families with X-linked mental retardation, Vulto-van Silfhout et al. (2015) identified CUL4B mutations in affected members of 8 families (2.0%). Subsequent screening of 29 patients with malformations of cortical development identified CUL4B mutations in 3 patients from 2 families. Ten different mutations were identified in the 10 families, including 5 truncating mutations, 2 splice site variants, an in-frame deletion, an in-frame duplication, and a missense variant (see, e.g., 300304.0005 and 300304.0006). Some of the patients were found to have variable malformations of cerebral development, suggesting that CUL4B has a role in this process.


Cytogenetics

In a patient with X-linked mental retardation with relative macrocephaly, short stature, lack of speech development, hypogonadism, and abnormal gait, Isidor et al. (2010) identified a 60-kb de novo deletion at chromosome Xq24 that encompassed the 3-prime region of the CUL4B gene and the MCTS1 gene (300587). Isidor et al. (2010) concluded that the deletion would result in premature termination and nonsense-mediated mRNA decay of CUL4B.

In a monozygotic twin pair with X-linked mental retardation, Ravn et al. (2012) identified a 28-kb deletion on the X chromosome, which partially encompassed the CUL4B gene and which was inherited from the unaffected mother. Using quantitative PCR, Ravn et al. (2012) mapped the proximal breakpoint within intron 4 of CUL4B and the distal breakpoint 1,000 bp downstream of the 3-prime UTR. X-inactivation studies in the unaffected mother revealed an extremely skewed X-inactivation pattern, consistent with her being an unaffected carrier.


REFERENCES

  1. Cabezas, D. A., Slaugh, R., Abidi, F., Arena, J. F., Stevenson, R. E., Schwartz, C. E., Lubs, H. A. A new X linked mental retardation (XLMR) syndrome with short stature, small testes, muscle wasting, and tremor localises to Xq24-q25. J. Med. Genet. 37: 663-668, 2000. [PubMed: 10978355] [Full Text: https://doi.org/10.1136/jmg.37.9.663]

  2. Gong, Y., Wei, J., Shao, C., Guo, Y., Chen, B., Guo, C., Warman, M. Mapping of the gene responsible for Smith-Fineman-Myers syndrome to Xq25. Chinese J. Med. Genet. 16: 277-280, 1999. Note: Article in Chinese. [PubMed: 10514530]

  3. Hamel, B. C. J., Smits, A. P. T., Otten, B. J., van den Helm, B., Ropers, H. H., Mariman, E. C. M. Familial X-linked mental retardation and isolated growth hormone deficiency: clinical and molecular findings. Am. J. Med. Genet. 64: 35-41, 1996. [PubMed: 8826446] [Full Text: https://doi.org/10.1002/(SICI)1096-8628(19960712)64:1<35::AID-AJMG5>3.0.CO;2-Q]

  4. Isidor, B., Pichon, O., Baron, S., David, A., Le Caignec, C. Deletion of the CUL4B gene in a boy with mental retardation, minor facial anomalies, short stature, hypogonadism, and ataxia. Am. J. Med. Genet. 152A: 175-180, 2010. [PubMed: 20014135] [Full Text: https://doi.org/10.1002/ajmg.a.33152]

  5. Kerzendorfer, C., Whibley, A., Carpenter, G., Outwin, E., Chiang, S.-C., Turner, G., Schwartz, C., El-Khamisy, S., Raymond, F. L., O'Driscoll, M. Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks. Hum. Molec. Genet. 19: 1324-1334, 2010. [PubMed: 20064923] [Full Text: https://doi.org/10.1093/hmg/ddq008]

  6. Liu, Q., Gong, Y., Chen, B., Guo, C., Li, J., Guo, Y. [Linkage analysis of X-linked nuclear protein gene in Smith-Fineman-Myers syndrome.] Chinese J. Med. Genet. 19: 22-25, 2002. Note: Article in Chinese. [PubMed: 11836680]

  7. Liu, Q. J., Gong, Y. Q., Li, J. X., Zhang, X. Y., Gao, G. M., Guo, Y. S. [Fine mapping of Smith-Fineman-Myers syndrome and exclusion of GPC3, GPCR2, MST4 and GLUD2 as candidate genes.] Chinese J. Med. Genet. 21: 198-202, 2004. Note: Article in Chinese. [PubMed: 15192816]

  8. Londin, E. R., Adijanto, J., Philp, N., Novelli, A., Vitale, E., Perria, C., Serra, G., Alesi, V., Surrey, S., Fortina, P. Donor splice-site mutation in CUL4B is likely cause of X-linked intellectual disability. Am. J. Med. Genet. 164A: 2294-2299, 2014. [PubMed: 24898194] [Full Text: https://doi.org/10.1002/ajmg.a.36629]

  9. Ravn, K., Lindquist, S. G., Nielsen, K., Dahm, T. L., Tumer, Z. Deletion of CUL4B leads to concordant phenotype in a monozygotic twin pair. (Letter) Clin. Genet. 82: 292-294, 2012. [PubMed: 22182342] [Full Text: https://doi.org/10.1111/j.1399-0004.2011.01839.x]

  10. Tarpey, P. S., Raymond, F. L., O'Meara, S., Edkins, S., Teague, J., Butler, A., Dicks, E., Stevens, C., Tofts, C., Avis, T., Barthorpe, S., Buck, G. {and 41 others}: Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet. 80: 345-352, 2007. [PubMed: 17236139] [Full Text: https://doi.org/10.1086/511134]

  11. Tarpey, P. S., Smith, R., Pleasance, E., Whibley, A., Edkins, S., Hardy, C., O'Meara, S., Latimer, C., Dicks, E., Menzies, A., Stephens, P., Blow, M., and 67 others. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nature Genet. 41: 535-543, 2009. [PubMed: 19377476] [Full Text: https://doi.org/10.1038/ng.367]

  12. Vitale, E., Specchia, C., Devoto, M., Angius, A., Rong, S., Rocchi, M., Schwalb, M., Demelas, L., Paglietti, D., Manca, S., Mastropaolo, C., Serra, G. Novel X-linked mental retardation syndrome with short stature maps to Xq24. Am. J. Med. Genet. 103: 1-8, 2001. [PubMed: 11562927] [Full Text: https://doi.org/10.1002/ajmg.1495]

  13. Vulto-van Silfhout, A. T., Nakagawa, T., Bahi-Buisson, N., Haas, S. A., Hu, H., Bienek, M., Vissers, L. E. L. M., Gilissen, C., Tzschach, A., Busche, A., Musebeck, J., Rump, P., Mathijssen, I. B., and 32 others. Variants in CUL4B are associated with cerebral malformations. Hum. Mutat. 36: 106-117, 2015. [PubMed: 25385192] [Full Text: https://doi.org/10.1002/humu.22718]

  14. Wei, J., Chen, B., Jiang, Y., Yang, Y., Guo, Y. Smith-Fineman-Myers syndrome: report on a large family. Am. J. Med. Genet. 47: 307-311, 1993. [PubMed: 8135271] [Full Text: https://doi.org/10.1002/ajmg.1320470302]

  15. Zou, Y., Liu, Q., Chen, B., Zhang, X., Guo, C., Zhou, H., Li, J., Gao, G., Guo, Y., Yan, C., Wei, J., Shao, C., Gong, Y. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet. 80: 561-566, 2007. [PubMed: 17273978] [Full Text: https://doi.org/10.1086/512489]


Contributors:
Cassandra L. Kniffin - updated : 9/3/2015
Cassandra L. Kniffin - updated : 3/23/2015
Jill A. Fahrner - updated : 4/5/2013
George E. Tiller - updated : 11/14/2011
Cassandra L. Kniffin - updated : 1/5/2011
Victor A. McKusick - updated : 1/18/2007

Creation Date:
Michael J. Wright : 8/15/2001

Edit History:
carol : 08/21/2021
alopez : 09/09/2015
ckniffin : 9/3/2015
alopez : 3/25/2015
mcolton : 3/23/2015
ckniffin : 3/23/2015
carol : 9/9/2013
carol : 4/5/2013
carol : 11/17/2011
terry : 11/14/2011
carol : 10/26/2011
wwang : 1/24/2011
ckniffin : 1/5/2011
carol : 11/30/2010
alopez : 10/6/2009
alopez : 1/19/2007
terry : 1/18/2007
ckniffin : 7/20/2005
alopez : 8/15/2001